Which adults with sickle cell disease need an evaluation for pulmonary embolism?-Reference-Cited by-同舟云学术

Which adults with sickle cell disease need an evaluation for pulmonary embolism?

Published:2021-09 Issue:3 Volume:195 Page:447-455
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

El‐Amin Nadirah¹^ORCID,Lauzon Steven D.²,Nietert Paul J.³,Kanter Julie⁴

Affiliation:

1. Division of Pediatric Hematology‐Oncology Virginia Commonwealth University Richmond VAUSA

2. Eli Lilly and Company Indianapolis INUSA

3. Department of Public Health Sciences Medical University of South Carolina Charleston SCUSA

4. Division of Hematology and Oncology University of Alabama at Birmingham Birmingham AL USA

Funder

NIH Clinical Center

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17552

Reference35 articles.

1. Centers for Disease Control and Prevention.Sickle Cell Disease: Health Care Professionals: Data & Statistics. Centers for Disease Control and Prevention. Department of Health and Human Services. Available at http://www.cdc.gov/ncbddd/sicklecell/data.html.

2. Pathophysiology of Sickle Cell Disease

3. Sickle Cell Disease

4. Hypercoagulable state in sickle cell disease

5. Hypercoagulability in sickle cell disease: a curious paradox

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020;European Journal of Haematology;2023-06-09

2. New Clues to Cardiovascular Disease: Erythrocyte Lifespan;Aging and disease;2023

3. Limited value of the D‐dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait;British Journal of Haematology;2022-05-13

4. Confirmation of the utility of the Wells’ Score for pulmonary embolism in patients with sickle cell disease;Journal of Thrombosis and Thrombolysis;2022-04-19